UPDATE: Corbus Pharma (CRBP) Mentioned Cautiously by Adam Feuerstein

October 25, 2016 8:49 AM EDT
Get Alerts CRBP Hot Sheet
Trade CRBP Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

(Updated - October 25, 2016 8:54 AM EDT)

Corbus Pharma (NASDAQ: CRBP) was mentioned cautiously in an article by Adam Feuerstein. According to to the report, an unnamed fund manager who is short the stock said the company's only pipeline drug, Resunab, doesn't work.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hedge Funds, Short Sales, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment